Smith & Nephew PLC Asset Resilience Ratio

Latest as of December 2023: -0.69%

Smith & Nephew PLC asset resilience ratio. Smith & Nephew PLC (SN) has an Asset Resilience Ratio of -0.69% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SN days of operational coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

GBX-69.00 Million
≈ $-8.40K USD Cash + Short-term Investments

Total Assets

GBX9.99 Billion
≈ $1.22 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Smith & Nephew PLC (1985–2023)

Asset resilience ratio of Smith & Nephew PLC from 1985 to 2023. This chart shows how Smith & Nephew PLC's Asset Resilience Ratio has changed over time. Read SN total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Smith & Nephew PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see SN current and non-current assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents GBX0.00 0%
Short-term Investments GBX-69.00 Million -0.69%
Total Liquid Assets GBX-69.00 Million -0.69%

Asset Resilience Insights

  • Limited Liquidity: Smith & Nephew PLC maintains only -0.69% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Smith & Nephew PLC Industry Peers by Asset Resilience Ratio

Compare Smith & Nephew PLC's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
GN Store Nord
CO:GN
Medical Devices -4.56%
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
Medical Devices 6.09%
Polynovo Ltd
AU:PNV
Medical Devices 0.04%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
VIROMED MEDICAL NA O.N.
XETRA:VME
Medical Devices 0.03%
Affluent Medical SAS
PA:AFME
Medical Devices 0.03%
DRGEM Corporation
KQ:263690
Medical Devices 2.12%

Smith & Nephew PLC Asset Resilience Ratio by Year (1985–2023)

Smith & Nephew PLC asset resilience ratio by year from 1985 to 2023. The table below shows the annual Asset Resilience Ratio data for Smith & Nephew PLC.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 -0.69% GBX-69.00 Million
≈ $-8.40K
GBX9.99 Billion
≈ $1.22 Million
+0.98pp
2021-12-31 -1.67% GBX-182.00 Million
≈ $-22.14K
GBX10.92 Billion
≈ $1.33 Million
-0.46pp
2020-12-31 -1.21% GBX-133.00 Million
≈ $-16.18K
GBX11.01 Billion
≈ $1.34 Million
-0.07pp
2019-12-31 -1.14% GBX-106.00 Million
≈ $-12.90K
GBX9.30 Billion
≈ $1.13 Million
+0.00pp
2018-12-31 -1.14% GBX-92.00 Million
≈ $-11.19K
GBX8.06 Billion
≈ $980.55K
-0.35pp
2017-12-31 -0.79% GBX-62.00 Million
≈ $-7.54K
GBX7.87 Billion
≈ $957.06K
-0.80pp
2015-12-31 0.01% GBX1.00 Million
≈ $121.67
GBX7.17 Billion
≈ $872.02K
-2.95pp
2012-12-31 2.96% GBX167.00 Million
≈ $20.32K
GBX5.64 Billion
≈ $686.47K
-0.03pp
2011-12-31 2.99% GBX142.00 Million
≈ $17.28K
GBX4.75 Billion
≈ $577.57K
+2.68pp
2009-12-31 0.31% GBX14.00 Million
≈ $1.70K
GBX4.57 Billion
≈ $555.43K
-4.16pp
2005-12-31 4.47% GBX133.00 Million
≈ $16.18K
GBX2.98 Billion
≈ $362.09K
-2.12pp
2004-12-31 6.59% GBX192.27 Million
≈ $23.39K
GBX2.92 Billion
≈ $355.22K
-8.84pp
2003-12-31 15.43% GBX342.86 Million
≈ $41.72K
GBX2.22 Billion
≈ $270.44K
+15.33pp
1995-12-31 0.10% GBX1.24 Million
≈ $150.41
GBX1.27 Billion
≈ $154.82K
-0.13pp
1994-12-31 0.22% GBX2.97 Million
≈ $361.42
GBX1.32 Billion
≈ $160.83K
0.00pp
1993-12-31 0.23% GBX2.96 Million
≈ $359.95
GBX1.31 Billion
≈ $159.01K
-0.77pp
1991-12-31 0.99% GBX15.72 Million
≈ $1.91K
GBX1.58 Billion
≈ $192.56K
-6.44pp
1990-12-31 7.43% GBX114.00 Million
≈ $13.87K
GBX1.53 Billion
≈ $186.61K
-1.81pp
1989-12-31 9.24% GBX125.00 Million
≈ $15.21K
GBX1.35 Billion
≈ $164.62K
+3.48pp
1988-12-31 5.76% GBX73.34 Million
≈ $8.92K
GBX1.27 Billion
≈ $154.90K
-2.86pp
1987-12-31 8.62% GBX105.86 Million
≈ $12.88K
GBX1.23 Billion
≈ $149.34K
+2.47pp
1986-12-31 6.16% GBX54.70 Million
≈ $6.66K
GBX888.50 Million
≈ $108.10K
-2.22pp
1985-12-31 8.37% GBX53.88 Million
≈ $6.56K
GBX643.40 Million
≈ $78.28K
--
pp = percentage points

About Smith & Nephew PLC

LSE:SN UK Medical Devices
Market Cap
$112.79 Million
GBX927.01 Billion GBX
Market Cap Rank
#18547 Global
#104 in UK
Share Price
GBX1107.50
Change (1 day)
-1.20%
52-Week Range
GBX982.40 - GBX1417.50
All Time High
GBX1690.00
About

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; t… Read more